Green tea is a type of tea that is made from Camellia sinensis leaves that have not undergone the same withering and oxidation process used to make oolong and black tea. Green tea originated in China, but its production has spread to many countries in Asia.
Several varieties of green tea exist, which differ substantially because of the variety of C. sinensis used, growing conditions, horticultural methods, production processing, and time of harvest.
- 1 History
- 2 Brewing and serving
- 3 Extracts
- 4 Health effects
- 5 Production
- 6 See also
- 7 References
- 8 External links
A book written by Lu Yu in 600-900 AD (Tang Dynasty), "Tea Classic" (simplified Chinese: 茶经; traditional Chinese: 茶經; pinyin: chájīng), is considered important in green tea history. The Kissa Yojoki (喫茶養生記 Book of Tea), written by Zen priest Eisai in 1191, describes how drinking green tea may affect five vital organs, the shapes of tea plants, flowers and leaves, and how to grow and process tea leaves.
Brewing and serving
Steeping, or brewing, is the process of making tea, generally using two grams of tea per 100 ml of water or about 1 teaspoon of green tea per 150 ml cup. Higher-quality teas, like gyokuro, use more tea leaves and are steeped multiple times for short durations.
Steeping temperatures range from 61°C (142°F) to 87°C (189°F) and times from 30 seconds to three minutes.
Generally, lower-quality green teas are steeped hotter and longer while higher-quality teas are steeped cooler and shorter, but usually for multiple times (2-3 typically). Steeping too hot or for too long results in the release of excessive amounts of tannins, leading to a bitter, astringent brew, regardless of initial quality. The brew’s taste is also affected by the steeping technique. Two important techniques are to warm the steeping container beforehand to prevent the tea from immediately cooling down and to leave the tea leaf in the pot and gradually add more hot water as you drink the tea.
Green tea leaves are initially processed by soaking in an alcohol solution, which may be further concentrated to various levels; byproducts of the process are also packaged and used. Extracts may be sold in liquid, powder, capsule, or tablet form. Decaffeinated versions are also available.
|Nutritional value per 100 g (3.5 oz)|
|Energy||4 kJ (0.96 kcal)|
|Percentages are roughly approximated using US recommendations for adults.|
Regular green tea is 99.9% water, provides 1 Calorie per 100 mL serving, is devoid of significant nutrient content (table) and contains phytochemicals, such as polyphenols and caffeine. Polyphenols found in green tea include epigallocatechin gallate (EGCG), epicatechin gallate, epicatechins and flavanols, which have antioxidant, anticarcinogen, anti-inflammatory, and anti-radiation biochemical effects in vitro. Other components include three kinds of flavonoids, known as kaempferol, quercetin, and myricetin. A remarkably higher content of myricetin is detected in tea and its extracts than in many other plants, and this high concentration of myricetin may have some implications for the experimentally-observed bioactivity of tea and its extracts in vitro.
Although numerous claims have been made for the health benefits of green tea, human clinical research has not provided conclusive evidence of any effects. In 2011, a panel of scientists published a report on the claims for health effects at the request of the European Commission: in general they found that the claims made for green tea were not supported by sufficient scientific evidence. Although the mean content of flavonoids and catechins in a cup of green tea is higher than that in the same volume of other food and drink items that are traditionally considered to promote health, flavonoids and catechins have no proven biological effect in humans.
There is no conclusive evidence that green tea helps to prevent or treat cancer in people. A review of existing studies concluded that while suggestive evidence existed, it did not amount to a clear indication of benefit.
Daily consumption of black tea (but not green tea) has been associated with a significant reduction in death from all cancers. There is limited evidence to suggest that green tea consumption may be associated with a slightly lower risk of esophageal cancer in the Chinese population, a lower risk of lung cancer in women, and a lower risk of oral cancer in Asian people. A 2015 meta-analysis of nine prospective cohort studies concluded that a high amount of green tea consumption may be associated with a lower risk of liver cancer in Asian women. This association was not seen in Asian men or when one cup of green tea was consumed daily. Similarly, another analysis of observational data conducted in 2012 suggested that green tea consumption may have a favorable effect on lung cancer risk. The observed effect was strongest in those who consumed more than seven cups of green tea daily. A 2011 meta-analysis of epidemiological studies found limited evidence that green tea consumption may be associated with a moderately reduced risk of liver cancer in Chinese and Japanese people. Limited evidence suggests that green tea consumption is not associated with the risk of developing pancreatic cancer or prostate cancer. The link between green tea consumption and stomach cancer risk is unclear due to inconsistent evidence.
Daily consumption of green tea has been associated with a lower risk of death from cardiovascular disease. In a 2015 meta-analysis of observational studies, an increase in one cup of green tea per day was associated with a 5% lower risk of death from cardiovascular causes. Green tea consumption may be associated with a reduced risk of stroke. A 2013 Cochrane review of randomized controlled trials concluded that green tea consumption for 3–6 months appears to lower systolic and diastolic blood pressures a small amount (about 3 mm Hg each). Additional analyses examining the effects of long-term green tea consumption on blood pressure have reached similar conclusions.
Drinking green tea or taking green tea supplements decreases the blood concentration of total cholesterol (about 7 mg/dL), LDL cholesterol (about 2 mg/dL), and does not affect the concentration of HDL cholesterol. A 2013 Cochrane review performed a meta-analysis of longer-term randomized controlled trials (>3 months duration) and concluded that green tea consumption lowers total and LDL cholesterol concentrations in the blood.
A 2015 systematic review and meta-analysis of 11 randomized controlled trials found that green tea consumption was not significantly associated with lower plasma levels of C-reactive protein levels (a marker of inflammation).
Daily consumption of green tea is significantly associated with a lower risk of death from any cause; an increase of one cup of green tea per day is linked with a 4% lower risk of death from any cause. A separate analysis found an increase of three cups of green tea per day was associated with a lower risk of death from any cause.
There is no conclusive evidence that green tea aids in weight loss.
Moderate, regular, and habitual consumption of green tea is safe; however, there are reports of liver toxicity in humans after consuming high doses (10–29 mg/kg/day) of green tea extract dietary supplements, and high doses may act as a pro-oxidant to damage DNA.
Growing, harvesting and processing
Green tea is processed and grown in a variety of ways, depending on the type of green tea desired. As a result of these methods, maximum amounts of polyphenols and volatile organic compounds are retained, affecting aroma and taste. The growing conditions can be broken down into two basic types − those grown in the sun and those grown under the shade. The green tea plants are grown in rows that are pruned to produce shoots in a regular manner, and in general are harvested three times per year. The first flush takes place in late April to early May. The second harvest usually takes place from June through July, and the third picking takes place in late July to early August. Sometimes, there will also be the fourth harvest. It is the first flush in the spring that brings the best-quality leaves, with higher prices to match.
Green tea is processed using either artisanal or modern methods. Sun-drying, basket or charcoal firing, or pan-firing are common artisanal methods. Oven-drying, tumbling, or steaming are common modern methods. Processed green teas, known as aracha are stored under low humidity refrigeration in 30- or 60-kg paper bags at 0–5 °C (32–41 °F). This aracha has yet to be refined at this stage, with a final firing taking place before blending, selection and packaging take place. The leaves in this state will be re-fired throughout the year as they are needed, giving the green teas a longer shelf-life and better flavor. The first flush tea of May will readily store in this fashion until the next year's harvest. After this re-drying process, each crude tea will be sifted and graded according to size. Finally, each lot will be blended according to the blending order by the tasters and packed for sale.
Production by country
|2006 Green tea production and export (in thousands of metric tons)
Import of Japanese tea
||This section needs to be updated. (October 2016)|
On 17 June 2011, radioactive cesium of 1,038 becquerels per kilogram was detected at Charles de Gaulle airport in France in tea leaves imported from Shizuoka Prefecture, Japan as a result of the Fukushima Daiichi nuclear disaster, which was more than twice as much as the restricted amount of 500 becquerels per kilogram designated by the European Union, and the government of France announced that they rejected the tea leaves, which amounted to 162 kilograms (357 lb). The governor of Shizuoka Prefecture Heita Kawakatsu stated that "there is absolutely no problem when they [people] drink them because it will be diluted to about ten becquerels per kilogram when they steep them even if the leaves have 1,000 becquerels per kilogram," which was a consequence of own examinations of the prefecture. Minister for Consumer Affairs and Food Safety Renhō stated on 3 June 2011, that "there are cases in which aracha are sold as furikake [condiments sprinkled on rice] and so on and they are eaten as they are, therefore we think that it is important to inspect tea leaves including aracha from the viewpoint of consumers' safety."
- Khan N, Mukhtar H (2013). "Tea and health: studies in humans". Current pharmaceutical design (Literature Review). 19 (34): 6141–7. doi:10.2174/1381612811319340008. PMC . PMID 23448443.
- Dattner, Christine; Boussabba, Sophie (2003). Emmanuelle Javelle, ed. The Book of Green Tea. Universe Books. p. 13. ISBN 978-0-7893-0853-5.
- "Green tea". Complementary and Alternative Medicine Guide. University of Maryland Medical Center. Retrieved 3 May 2015.
- I.T. Johnson & G. Williamson, Phytochemical functional foods, Cambridge, UK: Woodhead Publishing, 2003, pp. 135-145
- "Update on the USP Green Tea Extract Monograph". USP. April 10, 2009.
- A.H. Pressman & S. Buff, The complete idiot's guide to vitamins and minerals, New York: New York Alpha Books, 1997, p. 283.
- A. Bascom, Incorporating herbal medicine into clinical practice, Philadelphia: F.A. Davis Company, 2002, p. 153.
- Committee on Diet, Nutrition, and Cancer, Assembly of Life Sciences, National Research Council, Diet, nutrition, and cancer, Washington: D.C National Academies Press, 1982, p. 286.
- "Scientific Opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins in green tea, and improvement of endothelium-dependent vasodilation (ID 1106, 1310), maintenance of normal blood pressure (ID 1310, 2657), maintenance of normal blood glucose concentrations (ID 1108), maintenance of normal blood LDL cholesterol concentrations (ID 2640), protection of the skin from UV-induced (including photo-oxidative) damage (ID 1110, 1119), protection of DNA from oxidative damage (ID 1120, 1121), protection of lipids from oxidative damage (ID 1275), contribution to normal cognitive function (ID 1117, 2812), "cardiovascular system" (ID 2814), "invigoration of the body" (ID 1274, 3280), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1118), "immune health" (ID 1273) and "mouth" (ID 2813) pursuant to Article 13(1) of Regulation (EC) No 1924/2006". European Food Safety Authority. 8 April 2011. Retrieved 9 November 2014.
- Boehm K, Borrelli F, Ernst E, et al. (2009). "Green tea (Camellia sinensis) for the prevention of cancer". Cochrane Database Syst Rev (Systematic review) (3): CD005004. doi:10.1002/14651858.CD005004.pub2. PMID 19588362.
- USDA Database for the Flavonoid Content of Selected Foods, Release 2.1 (2007)
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2, 3 European Food Safety Authority (EFSA), Parma, Italy (2010). "Scientific Opinion on the substantiation of health claims related to various food(s)/food constituent(s) and protection of cells from premature aging, antioxidant activity, antioxidant content and antioxidant properties, and protection of DNA, proteins and lipids from oxidative damage pursuant to Article 13(1) of Regulation (EC) No 1924/20061" (PDF). EFSA Journal. 8 (2): 1489. doi:10.2903/j.efsa.2010.1489.
- Johnson R, Bryant S, Huntley AL (December 2012). "Green tea and green tea catechin extracts: an overview of the clinical evidence". Maturitas (Review). 73 (4): 280–7. doi:10.1016/j.maturitas.2012.08.008. PMID 22986087.
In conclusion, whilst there is a considerable body of evidence for green tea with some of it suggesting a positive effect, it is difficult to be definitive as to its health benefits.
- Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D (July 2015). "Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies". Br J Nutr (Meta-analysis). 114: 1–11. doi:10.1017/S0007114515002329. PMID 26202661.
- Zheng JS, Yang J, Fu YQ, Huang T, Huang YJ, Li D (January 2013). "Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies". Nutr Cancer (Systematic Review and Meta-Analysis). 65 (1): 1–16. doi:10.1080/01635581.2013.741762. PMID 23368908.
- Wang L, Zhang X, Liu J, Shen L, Li Z (October 2014). "Tea consumption and lung cancer risk: a meta-analysis of case-control and cohort studies". Nutrition (Meta-Analysis). 30 (10): 1122–7. doi:10.1016/j.nut.2014.02.023. PMID 25194612.
- Wang W, Yang Y, Zhang W, Wu W (April 2014). "Association of tea consumption and the risk of oral cancer: a meta-analysis". Oral Oncol (Meta-Analysis). 50 (4): 276–81. doi:10.1016/j.oraloncology.2013.12.014. PMID 24389399.
- Huang YQ, Lu X, Min H, Wu QQ, Shi XT, Bian KQ, Zou XP (July 2015). "Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations". Nutrition (Meta-Analysis). 32: 3–8. doi:10.1016/j.nut.2015.05.021. PMID 26412579.
- Wang Y, Yu X, Wu Y, Zhang D (November 2012). "Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies". Lung Cancer (Meta-Analysis). 78 (2): 169–70. doi:10.1016/j.lungcan.2012.08.009. PMID 22964413.
- Fon Sing M, Yang WS, Gao S, Gao J, Xiang YB (May 2011). "Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis". European Journal of Cancer Prevention (Meta-Analysis). 20 (3): 157–65. doi:10.1097/CEJ.0b013e3283447497. PMID 21403523.
- Zeng JL, Li ZH, Wang ZC, Zhang HL (October 2014). "Green tea consumption and risk of pancreatic cancer: a meta-analysis". Nutrients (Meta-Analysis). 6 (11): 4640–50. doi:10.3390/nu6114640. PMC . PMID 25353660.
- Lin YW, Hu ZH, Wang X, Mao QQ, Qin J, Zheng XY, Xie LP (February 2014). "Tea consumption and prostate cancer: an updated meta-analysis". World J Surg Oncol (Meta-Analysis). 12: 38. doi:10.1186/1477-7819-12-38. PMC . PMID 24528523.
- Hou IC, Amarnani S, Chong MT, Bishayee A (June 2013). "Green tea and the risk of gastric cancer: epidemiological evidence". World J Gastroenterol (Review). 19 (24): 3713–22. doi:10.3748/wjg.v19.i24.3713. PMC . PMID 23840110.
- Jia L, Liu FT (December 2013). "Why bortezomib cannot go with 'green'?". Cancer Biol Med (Review). 10 (4): 206–13. doi:10.7497/j.issn.2095-3941.2013.04.004. PMC . PMID 24349830.
- Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J (February 2015). "Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies". Eur J Epidemiology (Systematic Review and Meta-Analysis). 30 (2): 103–13. doi:10.1007/s10654-014-9960-x. PMID 25354990.
- Arab L, Khan F, Lam H (December 2013). "Tea consumption and cardiovascular disease risk". Am J Clin Nutr (Review). 98 (6 Suppl): 1651S–1659S. doi:10.3945/ajcn.113.059345. PMID 24172310.
- Larsson SC (January 2014). "Coffee, tea, and cocoa and risk of stroke". Stroke (Review). 45 (1): 309–14. doi:10.1161/STROKEAHA.113.003131. PMID 24326448.
- Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L, Rees K (June 2013). "Green and black tea for the primary prevention of cardiovascular disease" (PDF). Cochrane Database Syst Rev (Systematic Review and Meta-Analysis). 6: CD009934. doi:10.1002/14651858.CD009934.pub2. PMID 23780706.
- Liu G, Mi XN, Zheng XX, Xu YL, Lu J, Huang XH (October 2014). "Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials". Br J Nutr (Meta-Analysis). 112 (7): 1043–54. doi:10.1017/S0007114514001731. PMID 25137341.
- Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, Khosravi-Boroujeni H (September 2014). "Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials". Eur J Nutr (Systematic Review and Meta-Analysis). 53 (6): 1299–1311. doi:10.1007/s00394-014-0720-1. PMID 24861099.
- Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, Mi M (September 2014). "Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials". Sci Rep (Meta-Analysis). 4: 6251. doi:10.1038/srep06251. PMC . PMID 25176280.
- Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD, Mi MT (August 2013). "Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials". Am J Clin Nutr (Meta-Analysis). 98 (2): 340–8. doi:10.3945/ajcn.112.052746. PMID 23803878.
- Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH (April 2013). "Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials". Am J Clin Nutr (Meta-Analysis). 97 (4): 750–62. doi:10.3945/ajcn.111.032573. PMID 23426037.
- Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH (August 2011). "Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials". Am J Clin Nutr (Meta-Analysis). 94 (2): 601–10. doi:10.3945/ajcn.110.010926. PMID 21715508.
- Serban C, Sahebkar A, Antal D, Ursoniu S, Banach M (September 2015). "Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials". Nutrition (Systematic review & meta-analysis). 31 (9): 1061–71. doi:10.1016/j.nut.2015.02.004. PMID 26233863.
- Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E (2012). "Green tea for weight loss and weight maintenance in overweight or obese adults". Cochrane Database Syst Rev (Systematic review). 12: CD008650. doi:10.1002/14651858.CD008650.pub2. PMID 23235664.
- Lambert JD, Sang S, Yang CS (April 2007), "Possible controversy over dietary polyphenols: benefits vs risks", Chem Res Toxicol, 20 (4): 583–5, doi:10.1021/tx7000515, PMID 17362033
- Heiss, Mary Lou; Heiss, Robert J. (2007), Hardcover, ed., The Story of Tea: A Cultural History and Drinking Guide, Ten Speed Press, pp. 56–69, ISBN 978-1-60774-172-5
- Green Tea Processing, O-cha.com, retrieved 2013-01-13
- Current situation and medium-term outlook (PDF), Intergovernmental Group on Tea, UN Food and Agriculture Organization, May 2008, p. 9
- "日本からの緑茶に基準超えるセシウム パリの空港で検出." (Japanese) Asahi Shimbun. 2011-06-18. Retrieved 2011-06-19.
- "静岡知事「飲用茶にすれば問題ない」 仏での検出受け." (Japanese) Asahi Shimbun. 2011-06-18. Retrieved 2011-06-19.
- "蓮舫内閣府特命担当大臣記者会見要旨（平成23年６月３日（金））." (Japanese) Consumer Affairs Agency. 2011-06-03. Retrieved 2011-06-19.
|Wikimedia Commons has media related to Green tea.|
- NCCIH - Green Tea Side Effects and Cautions (From the National Center for Complementary and Integrative Health)